ANGPT2 and cholangiocarcinoma: Serum levels of S100A9, MUC5AC, TGF-β1, angiopoietin-2, and CA19-9 were examined in 40 patients diagnosed with CCA, 40 non-CCA subjects, and 40 healthy individuals.